Net Income

With three international awards, Marina Pointe isn't just selling condos; it's cementing Tampa Bay's status as a premier global luxury destination.

CN moved record volumes of Canadian grain in 2025, fueled by a historic harvest. This article dives into the logistics, challenges, and competition.

Promising Phase 2 data shows a new DNA immunotherapy for advanced melanoma, delivered via a needle-free jet injector, significantly improves patient outcomes.

A new partnership aims to move AI from costly experiments to real-world value in biopharma, combining specialized agents with strategic implementation.

A joint venture of Elliott and Morning Calm has acquired City Office REIT, a bold move signaling a contrarian belief in the office market's recovery.

As Westwood One airs its 39th straight NFL playoffs, its strategy blends classic radio with digital reach, proving audio's lasting power in sports.

As Telus offers nearly 700 severance packages, unions warn of declining service quality, while data reveals a company grappling with cost pressures.

A new alliance aims to advance KFRX06, a unique Parkinson's therapy that goes beyond a single target to potentially offer a more comprehensive treatment.

A new $50M venture fund from Penn, BioNTech, and OUP aims to turn the university's breakthrough research into life-saving therapies faster than ever.

Meta's historic nuclear energy purchase signals a major shift in Big Tech's strategy to meet soaring AI power demands and reshape the US energy grid.

A new platform promises high daily returns for XRP investors by linking crypto to renewable energy, but a closer look reveals significant red flags.

Maria Montenegro, an AI and M&A expert, takes the helm of the CP & ESG unit, signaling a major push into tech-driven corporate compliance and performance.

After resolving manufacturing hurdles, Camurus' self-administered acromegaly treatment Oclaiz is back on track for US approval, promising new hope for patients.

The value furniture giant is going public, revealing strong growth and ambitious expansion plans. Can its "Everyday Low Prices" model win over Wall Street?

Rubico Inc.'s new $4 million offering sent its stock tumbling amid severe dilution concerns and red flags over its financial health and ability to fund growth.

At CES 2026, Jinxin Technology unveiled NAMI INSIGHT One, AI-powered learning glasses aiming to revolutionize education. But can it overcome the hurdles?

Prescryptive and Ilant Health unveil a direct-to-employer model for obesity drugs, promising transparent pricing and better clinical outcomes for employers.

Amid rising regulatory pressure, dxFeed's flawless performance in a critical industry-wide disaster recovery test sets a new benchmark for data reliability.

Manhattan Associates embeds agentic AI and advanced simulation tools into its platform, promising to boost retail productivity, profits, and customer loyalty.

Newly-formed materials giant Magnera reports Q1 results on Feb 5. Investors eye its path to profitability while the industry watches for key market signals.